| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.34▲ | 4.34▲ | 4.36▼ | 4.30▲ | 4.63▼ |
| MA10 | 4.32▲ | 4.32▲ | 4.32▲ | 4.45▼ | 4.80▼ |
| MA20 | 4.28▲ | 4.28▲ | 4.27▲ | 4.66▼ | 4.86▼ |
| MA50 | 4.29▲ | 4.44▼ | 4.57▼ | 4.85▼ | 5.01▼ |
| MA100 | 4.44▼ | 4.67▼ | 4.75▼ | 4.91▼ | N/A |
| MA200 | 4.70▼ | 4.82▼ | 4.89▼ | 5.15▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.016▲ | 0.028▲ | 0.036▲ | -0.042▼ | -0.069▼ |
| RSI | 53.468▲ | 50.420▲ | 48.510▼ | 38.970▼ | 40.575▼ |
| STOCH | 70.581 | 70.581 | 83.838▲ | 31.893 | 27.937 |
| WILL %R | -25.000 | -25.000 | -25.000 | -59.087 | -72.693 |
| CCI | 46.820 | 53.876 | 72.178 | -53.903 | -201.249▼ |
| MA | $RADX Price Crossed Above MA(7) | Set Alert |
|
Radiopharm Theranostics Shares RAD101 Phase IIb Update: 90% Hit Primary Endpoint in Brain Mets Study
Wednesday, March 25, 2026 02:52 AM
Radiopharm Theranostics (NASDAQ:RADX) executives and clinical investigators highlighted new interim findings from the company’s ongoing Phase IIb study of RAD101, a PET imaging tracer intended to help ...
|
|
Tuesday, March 24, 2026 07:50 AM
Radiopharm Theranostics (NASDAQ:RADX) announced interim findings from its Phase 2b clinical trial evaluating RAD 101, an imaging agent designed to detect recurrent brain metastases, according to a ...
|
|
Wednesday, March 11, 2026 04:29 PM
The last time I spoke about Radiopharm Theranostics (RADX), it was with a Seeking Alpha article entitled "Radiopharm Theranostics: Radiotherapeutic Biotech With PD-L1 And HER2 Targeting". With respect ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/03/26 | 4.39 | 4.39 | 4.35 | 4.35 | 5,648 |
| 30/03/26 | 4.20 | 4.45 | 4.11 | 4.34 | 70,070 |
| 27/03/26 | 4.20 | 4.39 | 4.1002 | 4.25 | 82,781 |
| 26/03/26 | 4.05 | 4.39 | 4.05 | 4.25 | 110,999 |
| 25/03/26 | 3.90 | 4.365 | 3.90 | 4.33 | 220,037 |
| 24/03/26 | 4.62 | 4.66 | 4.13 | 4.14 | 7,057,760 |
| 23/03/26 | 4.69 | 4.77 | 4.5601 | 4.64 | 13,822 |
| 20/03/26 | 4.51 | 4.94 | 4.4414 | 4.795 | 43,189 |
| 19/03/26 | 4.64 | 4.85 | 4.50 | 4.72 | 19,843 |
| 18/03/26 | 4.85 | 4.87 | 4.62 | 4.70 | 33,500 |
|
|
||||
|
|
||||
|
|